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Abstract Psychological distress contributes to impaired qual-
ity of life in hematological cancer patients. Stepped care treat-
ment, in which patients start with the least intensive treatment
most likely to work and only receive more intensive interven-
tions if needed, could improve distress. We aimed to evaluate
the outcome of stepped care treatment on psychological dis-
tress and physical functioning in patients treated with autolo-
gous stem cell transplantation for hematological malignancies.
In the present study, we performed a randomized clinical trial
with two treatment arms: stepped care and care as usual.
Baseline assessment and randomization occurred during pre-
transplant hospitalization. Stepped care was initiated after
6 weeks, consisting of (1) watchful waiting, (2) Internet-
based self-help intervention, and (3) face-to-face counseling/
psychopharmacological treatment/ referral. Follow-up mea-
surements were conducted at 13, 30, and 42 weeks after
transplantation. Stepped care (n=47) and care as usual (n=
48) were comparable on baseline characteristics. The uptake
of the intervention was low: 24 patients started with step 1, 23
with step 2, and none with step 3. Percentages of distressed
patients ranged from 4.1 to 9.7 %. Ten percent of patients
received external psychological or psychiatric care. No statis-
tically significant differences were found between stepped
care and care as usual on psychological distress or physical
functioning in intention to treat analyses, nor in per protocol
analyses. The stepped care program was not effective in de-
creasing psychological distress. The low intervention uptake,
probably related to the low levels of psychological distress,
offers an explanation for this outcome. Future research should
take into account patients’ specific care needs.
Netherlands Trial Registry identifier: NTR1770.
Keywords Depression . Anxiety . Quality of life .
Hematological neoplasms . Hematopoietic stem cell
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Background
For patients diagnosed with hematological malignancies, au-
tologous stem cell transplantation (auto-SCT) following high-
dose chemotherapy is a common treatment option. Treatment
with auto-SCT generally leads to improved survival, with an
overall 60 % probability of surviving 5 years from transplan-
tation [1]. At the same time, auto-SCT survivors are
confronted with impairments in their health-related quality
of life (QOL) [2, 3]. Before and shortly after auto-SCT, pa-
tients generally face impairments in physical, emotional, and
role functioning. Although most patients return to or surpass
pre-transplant levels of functioning in subsequent months and
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years, continuous impairments are observed in physical func-
tioning, role functioning, and global QOL [2, 3].
A strong predictor of QOL after auto-SCT is the pres-
ence of psychological distress [4, 5]. Psychological distress
is a multifactorial concept, encompassing common feelings
of vulnerability, sadness, and fears, as well as potentially
disabling problems such as depression, anxiety, or social
isolation [6]. In the present study, psychological distress is
defined as the presence of elevated depressive or anxiety
symptoms. Previous research shows large variation in the
prevalence of depressive and anxiety symptoms in the
period from pre-transplant to 1 year post-transplant.
Prevalence rates of 5 to 48 % have been reported for
elevated depressive symptoms, and 5 to 45 % for anxiety
symptoms [4, 7–10]; the period of initial hospitalization
has been pointed at as being most stressful [10, 11].
Patients with elevated depressive or anxiety symptoms be-
fore or during transplantation more often face impaired
post-transplant psychological functioning [4, 5, 12, 13]
and physical limitations [4].
Problem Solving Treatment is an effective intervention
for reducing psychological distress [14], also in cancer
survivors [15]. It aims at strengthening patients’ self-
management skills to solve present and future problems.
Patients learn to (a) prioritize problems which matter most
to them and which in principle can be solved, (b) analyze
the problem and generate alternative solutions, (c) select
methods for solution and implement these, and (d) evalu-
ate the results and prepare for the future. This may help
patients cope with the challenges they encounter related to
disease and treatment. Since psychological distress seems
to contribute to impaired QOL after auto-SCT, successful
treatment of psychological distress is expected to improve
patients’ QOL. In delivering treatment for psychological
distress, the stepped care approach has been strongly ad-
vocated [16]. In this approach, patients start with the least
intensive treatment that is most likely to work. Only those
patients insufficiently helped by the initial treatment re-
ceive more intensive and costly interventions. Stepped care
aims at an effective and efficient allocation of therapeutic
resources.
In the present study, psychological support, organized
according to a stepped care approach, was offered to pa-
tients treated with auto-SCT for hematological malignan-
cies. The steps included (1) watchful waiting; (2) Internet-
based self-help program, based on the principles of
Problem Solving Treatment; and (3) individual face-to-
face counseling, medication, or referral to other services.
We aimed to evaluate the outcome of stepped care on psy-
chological distress and the QOL domain physical function-
ing. It was hypothesized that stepped care would result in
improvement of psychological distress, and thereby in im-
provement of physical functioning.
Methods
Design
In this pragmatic two-armed randomized clinical trial, stepped
care was compared with care as usual. An extensive descrip-
tion of the study protocol has been published previously [17].
The study was approved by the Medical Ethics Committees of
the participating hospitals: VU University Medical Center,
Amsterdam, and Isala Clinics, Zwolle. All procedures follow-
ed were in accordance with the ethical standards of the
Medical Ethics Committees and with the Helsinki
Declaration of 1975, as revised in 2008. The trial was regis-
tered in the Netherlands Trial Registry (NTR1770).
Participants and setting
Patients were recruited from the hematology departments at
the two participating hospitals in the Netherlands between
August 2009 and April 2013. Eligibility criteria comprised a
diagnosis of hematological malignancy (multiple myeloma,
(non-)Hodgkin lymphoma, or acute leukemia), scheduled for
treatment with high-dose chemotherapy and auto-SCT; age
≥18 years; and life expectation >3 months. Exclusion criteria
comprised an insufficient command of the Dutch language,
and a contraindication for the stepped care approach (e.g.,
hospitalization in a mental health institute). All participants
provided written informed consent.
The majority of patients received follow-up care after auto-
SCT at the hospital where they had been transplanted.
However, 41 % of the study participants were redirected to
their local hospital for follow-up care.
Procedures
At hospital admission for high-dose chemotherapy and auto-
SCT, patients who provided informed consent filled in the
baseline questionnaire (T0). Subsequently, patients were allo-
cated at random to one of the two study arms: stepped care or
care as usual. Stepped care was initiated after a 6-week buffer
period, allowing for initial physical recovery. Follow-up mea-
surements were administered by mail at 13 weeks (T13),
30 weeks (T30), and 42 weeks (T42) after transplantation.
The design is illustrated in Fig. 1.
Randomization was performed by the second author, who
was not involved in data collection and analysis, using a ran-
dom digit generator. Randomization was stratified for treating
hospital (VU University Medical Center vs Isala Clinics) and
diagnosis (multiple myeloma vs lymphoma). Patients were
informed about their assignment by the first author during
the 6-week buffer period. Due to the nature of the intervention,
neither patients nor health care providers could be blinded to
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the intervention. Randomization and statistical analysis were
performed blindly.
Interventions
Under the assumption that all patients could benefit from im-
proved problem-solving skills, all patients in the experimental
study arm were, regardless of whether psychological distress
was present, provided with a stepped care program which
contained three steps: watchful waiting, an Internet-based
self-help intervention, and individual face-to-face
counseling/psychopharmacological treatment/referral to other
services (see below). At time of the randomization assign-
ment, patients were asked with which step they wanted to
start. Step 1 (watchful waiting) was the default choice, but
patients were allowed to start with step 2 or 3 if they wished
Fig. 1 Design of the randomized
clinical trial/CONSORT flow
diagram
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to. At 13- and 30-week follow-up, patients with elevated psy-
chological distress were contacted and asked if they wanted to
progress to a next step in the stepped care program.
Step 1: Watchful waiting Since psychological distress often
improves without requiring active intervention, the first step
consisted of 6 weeks of watchful waiting. This step was added
to the study protocol [17], as we noticed during the study that
there was a need for a less intensive program option: For some
patients, the Internet-based self-help intervention appeared to
be too intensive as the default first step of the program.
Therefore, we made the program more broadly accessible by
adding watchful waiting. At that point in time, 30 patients had
already been included in the study, of which 15 patients had
been randomly allocated to stepped care. Before adding this
step to the protocol, step 2 (Internet-based self-help interven-
tion) was the default choice.
Step 2: Internet-based self-help intervention Patients were
provided with an Internet-based self-help intervention, based
on the principles of Problem Solving Treatment. Previous
studies confirmed the effectiveness of this intervention in
treating psychological distress [18, 19]. The original interven-
tion, called Everything Under Control [18], was adapted to
our patient group [17] in close collaborationwith nurses, nurse
practitioners, and hematologist-oncologists from the
Department of Hematology: Specific information on disease
and treatment was added, and texts and examples were adjust-
ed to make sure these applied to auto-SCT patients. The inter-
vention consisted of fivemodules with information, examples,
and exercises. Patients were asked to work through one mod-
ule a week, with the advice to spend approximately 2 h per
module, and send their completed assignments to their coach.
Support was provided by a trained psychologist and consisted
of brief, weekly e-mails in reply to patients’ assignments and a
weekly standardized e-mail to announce a new module.
Support was merely intended to facilitate patients’ effective
use of the intervention. Patients could contact their coach at
any moment for additional support via e-mail or the website.
A small pilot test (n=3) was carried out before the start of the
study to ensure applicability and feasibility of the intervention.
For patients without access to the Internet, the intervention
was available in booklet. The content of the booklet was ex-
actly similar to the website. In these cases, coaching was ar-
ranged via telephone or e-mail.
Step 3: Individual face-to-face counseling, psychopharma-
cological treatment, or referral to other services For pa-
tients in step 3, a collaborative care team consisting of a con-
sultant psychiatrist, psychiatric nurse consultant, nurse practi-
tioner (Department of Hematology), hematologist-oncologist,
and patient was formed. This team, coordinated by the nurse
practitioner, evaluated the patient’s need for treatment and
developed a treatment plan. Diagnostic evaluation was per-
formed by the consultant psychiatrist, psychiatric nurse con-
sultant, and nurse practitioner, using the following instru-
ments: the anxiety and depression modules of the Composite
International Diagnostic Interview (CIDI), version 2.1 [20],
Camberwell Assessment of Need (CAN) [21], and Intermed
[22]. Subsequently, the psychiatric nurse consultant discussed
the following treatment options with the patient: individual
face-to-face counseling based on the principles of Problem
Solving Treatment, psychopharmacological treatment, and re-
ferral to other health care or social services.
In the control condition of the study, patients were provided
with care as usual. Care as usual represented regular care at
the Department of Hematology in the two hospitals. During
regular follow-up visits, emotional support was provided by
the hematologist-oncologists and nurses on an ad hoc basis. If
patients brought up any problem, hematologist-oncologists or
nurses could undertake action and/or refer patients to other
services.
Measures
The following validated and reliable self-report questionnaires
were included in the assessment battery: Hospital Anxiety and
Depression Scale (HADS) [23], European Organization for
Research and Treatment of Cancer Quality of Life
Questionnaire-C30 (EORTC QLQ-C30) [24] version 3.0,
Patient Health Questionnaire-9 (PHQ-9) [25], Spielberger
State-Trait Anxiety Inventory: state version (STAI-state) [26,
27], Social Problem Solving Inventory-Revised (SPSI-R)
[28], and the Dutch General Self-efficacy Scale (DGSS)
[29]. A checklist, specifically developed for this trial, was
used to collect data on additional supportive care patients re-
ceived. Demographic information was collected at baseline,
and medical data were extracted from the patient’s medical
record. To determine whether elevated psychological distress
was present, we used the HADS (cutoff ≥8 on one or both of
the subscales, or ≥15 on the overall questionnaire), PHQ-9
(cutoff ≥10), and STAI-state (cutoff ≥40).
The primary outcomes of the current study were psycho-
logical distress (anxiety and depression) (HADS), and physi-
cal functioning (EORTC QLQ-C30). Secondary outcomes in-
cluded emotional functioning and role functioning (EORTC
QLQ-C30), other measures of psychological distress (STAI,
PHQ), problem solving (SPSI-R), and self-efficacy (DGSS).
Data analysis
Descriptive statistics were used to compare baseline charac-
teristics of the experimental and control group, and to compare
baseline characteristics of dropouts and completers in the total
sample. Intention-to-treat and per-protocol analyses were con-
ducted. For the intention to treat analyses, linear mixed-model
108 Ann Hematol (2016) 95:105–114
analyses were performed to evaluate the difference in outcome
(psychological distress, physical functioning, and secondary
outcomes) between the experimental group and the control
group. A random intercept was used, and condition and time
were fixed effects. A group * time interaction was added to the
model to test for treatment effects over time. Based on pooled
pre-test standard deviations [30], effect sizes were calculated
for the estimated differences between T0 and T13, T0 and
T30, and T0 and T42, between groups. To test whether base-
line level of distress moderated the effect of the intervention in
the two groups, a three-way interaction term (baseline distress
* group * time) was added to the model. Since linear mixed-
model analysis is able to handle missing observations due to
dropout, no additional actions were undertaken for handling
missing data.
Two per-protocol analyses were carried out, following the
same procedure as in the intention-to-treat analyses. In the first
per-protocol analysis, we excluded patients in the experimental
group if (a) despite presence of elevated distress after complet-
ing watchful waiting or the Internet-based self-help program,
they did not enter a next step of the program; or (b) they
followed less than four lessons of the Internet-based self-help
intervention. In the second analysis, we only included patients
who had completed at least four lessons of the Internet-based
self-help program. Patients who had received psychological or
psychiatric care outside of the study were excluded from both
per protocol analyses. Data were analyzed using IBM SPSS
statistics version 20.0 (IBM SPSS Statistics for Windows,
Armonk, NY).
Sample size
The power calculation concerned the comparison at T30 com-
pared to T0 between the two groups (stepped care vs. care as
usual). A meta-analysis on Problem Solving Therapy for men-
tal and physical health problems has documented an effect
size of d=0.54, compared to treatment as usual [14]. Setting
d=0.5, alpha=0.05 (two tail), and beta=0.80, the required
sample size was 2×64=128 patients. A second power calcu-
lation was made, considering the difference in treatment effect
over time (T0, T13, T30, and T42). Setting the within-subject
correlation coefficient (rho) at 0.5, the required sample size
was 2×42=84 patients.
Results
Of 162 eligible patients, 99 (response rate 61.1 %) agreed to
participate, provided informed consent, filled in the baseline
questionnaire (T0), and were randomly assigned to one of the
two treatment arms. The main reason for non-participation
was considering participation to take too much energy or ef-
fort. Some patients refused study participation in general, and
a few patients had no interest in psychosocial research. After
randomization, four patients appeared to have completed the
baseline questionnaire only partly, and they declined further
participation. Data of these patients was therefore not ana-
lyzed. Of the remaining 95 patients, 78 % (T13), 66 %
(T30), and 63 % (T42) completed the follow-up assessments
(Fig. 1).
Table 1 presents the baseline demographic and clinical
characteristics of our sample. Patients in the two study arms
were comparable. When comparing baseline characteristics of
patients who completed the study and patients who dropped
out before the last assessment, completers were significantly
older and lived with a partner, had multiple myeloma (as op-
posed to lymphoma), and received high-dose melphalan
(HDM) as conditioning regimen more often (all P<0.05).
Overall, external psychological or psychiatric care (inde-
pendent of the study) was received by 10.3 % of patients
during the study period (5.9 % at T13, 5.7 % at T30, and
7.4 % at T42).
Of the 47 patients who started with the stepped care program,
24 patients started with step 1 (watchful waiting); 1 patient sub-
sequently entered step 2 because of psychological distress.
Twenty-three patients started with step 2 (Internet-based self-
help intervention), of which 15 entered this step by default, before
watchful waiting was added to the program. None of the patients
entered step 3 (individual face-to-face counseling, psychophar-
macological treatment, or referral). Except for one patient, all
patients followed only one step of the stepped care program.
In total, 24 patients took the Internet-based self-help inter-
vention. Ten patients completed the intervention (at least four
out of five lessons). Reasons for dropout (n=14) were feeling
capable of coping by themselves (nine patients); not wanting to
deal with psychosocial aspects of disease and treatment at this
point in time (three patients); being too ill to continue (one
patient); and feeling that one’s problems could not be addressed
well enough in a self-help intervention, but not wanting to
travel to our hospital for face-to-face counseling (one patient).
Dropout was independent of the presence of psychological dis-
tress: Of the eight patients with psychological distress who
entered step 2, 3 completed the intervention; of the 16 patients
without psychological distress, 8 completed the intervention.
In both study arms, HADS total scores were relatively low
on all four measurement points. However, the large standard
deviations in our sample point to substantial individual differ-
ences. Percentages of patients scoring ≥15 ranged from 4.1 to
9.7 %. Percentages of distressed patients on the HADS sub-
scales and other questionnaires are presented in Table 2.
The results of the intention to treat analyses are summa-
rized in Tables 3 and 4. Table 3 presents the observed means
and standard deviations of the HADS total scores, EORTC
physical functioning (primary outcomes), and secondary out-
comes. Table 4 summarizes the results of the linear mixed
models analyses. Comparing stepped care and care as usual
Ann Hematol (2016) 95:105–114 109
Table 1 Sample characteristics
Stepped care (n=47) Care as usual (n=48) P value
Gender, female, n (%) 16 (34.0) 14 (29.2) 0.61
Age in years, mean (s.d.) 53.3 (8.7) 55.5 (8.7) 0.23
BMI, mean (s.d.) 25.8 (4.0) 26.4 (3.2) 0.41
Living with partner, yes, n (%)a 33 (70.2) 40 (85.1) 0.08
Education, n (%)a 0.06
<4-year college degree 16 (34.0) 25 (53.2)
≥4-year college degree 31 (66.0) 22 (46.8)
Diagnosis, n (%) 0.77
Non-Hodgkin lymphoma 19 (40.4) 17 (35.4)
Hodgkin lymphoma 5 (10.6) 4 (8.3)
Multiple myeloma 23 (48.9) 27 (56.3)
Type of conditioning, n (%) 0.36
High-dose melphalan (HDM) 23 (48.9) 28 (58.3)
BEAM/Z-BEAM 24 (51.1) 19 (39.6)
Busulfan/cyclofosfamide – 1 (2.1)
Somatic comorbidities, n (%)a 0.39
None 6 (12.8) 2 (4.3)
1 19 (40.4) 18 (38.3)
2 8 (17.0) 12 (25.5)
3 or more 14 (29.8) 15 (31.9)
Remission status at time of transplantb 0.85
Complete remission 19 (44.2) 19 (42.2)
Not in complete remission 24 (55.8) 26 (57.8)
a Care as usual: 1 patient missing data
b Stepped care: 4 patients missing data; care as usual: 3 patients missing data
Table 2 Percentages of patients














(HADS total score, cutoff ≥15)
Total group 7.5 4.1 9.7 8.5
Stepped care 4.3 8.3 13.3 14.3
Care as usual 10.9 0 6.3 3.2
Depression
(HADS subscale, cutoff ≥8)
Total group 7.5 9.6 11.3 10.2
Stepped care 2.1 11.1 10.0 10.7
Care as usual 13.0 8.1 12.5 9.7
Anxiety
(HADS subscale, cutoff ≥8)
Total group 6.5 8.2 12.9 11.9
Stepped care 6.4 8.3 16.7 17.9
Care as usual 6.5 8.1 9.4 6.5
Depression
(PHQ, cutoff ≥10)
Total group 16.0 5.4 12.9 8.5
Stepped care 12.8 8.3 13.3 10.7
Care as usual 19.1 2.6 12.5 6.5
Anxiety
(STAI, cutoff ≥40)
Total group 27.7 19.2 19.4 20.3
Stepped care 23.4 22.2 16.7 14.3
Care as usual 31.9 16.2 21.9 25.8
SC stepped care, CAU care as usual, HADS Hospital Anxiety and Depression Scale, PHQ Patient Health
Questionnaire, STAI Spielberger State-Trait Anxiety Inventory
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on the HADS total scores and EORTC physical functioning,
no statistically significant differences were found. Baseline
level of distress did not moderate the effect of the intervention
on distress, nor on physical functioning, in the two groups
(P>0.10 at T13, T30, and T42; data not shown).
On the following secondary outcomes, no statistically sig-
nificant differences were found between stepped care and care
as usual: STAI anxiety, EORTC emotional functioning,
EORTC role functioning, PHQ depression, SPSI-R problem
solving, and DGSS self-efficacy (except for a significant dif-
ference on EORTC emotional functioning at 13 weeks, in
Table 3 Observed mean scores of primary and secondary outcomes
Stepped care N=47 Care as usual N=48




T0 6.72 (4.47) 7.26 (4.90)
T13 6.69 (4.96) 5.75 (3.45)
T30 6.53 (6.06) 6.38 (5.93)
T42 6.54 (6.44) 6.29 (4.55)
Depression
(HADS subscale)
T0 2.98 (2.24) 3.52 (3.38)
T13 3.17 (2.55) 2.73 (2.51)
T30 2.63 (2.91) 3.13 (4.03)
T42 2.64 (2.88) 2.87 (3.03)
Anxiety
(HADS subscale)
T0 3.74 (2.88) 3.74 (2.64)
T13 3.53 (2.89) 3.03 (2.21)
T30 3.90 (3.58) 3.25 (2.75)
T42 3.89 (3.93) 3.42 (2.43)
Physical functioning
(EORTC QLQ-C30)
T0 74.47 (20.06) 70.64 (19.59)
T13 74.25 (21.91) 74.05 (19.55)
T30 82.22 (17.00) 79.79 (23.74)




T0 80.50 (17.83) 79.89 (16.16)
T13 82.41 (16.64) 87.84 (13.55)
T30 84.17 (17.28) 84.38 (14.93)
T42 83.93 (17.85) 81.18 (14.59)
Role functioning
(EORTC QLQ-C30)
T0 59.22 (35.24) 57.09 (34.18)
T13 68.06 (28.56) 66.67 (24.46)
T30 75.00 (27.60) 75.52 (29.63)
T42 74.40 (27.02) 74.19 (27.50)
Anxiety
(STAI)
T0 35.06 (8.74) 35.15 (8.18)
T13 32.97 (8.76) 31.57 (7.90)
T30 32.60 (10.22) 33.44 (10.33)
T42 32.89 (11.93) 33.10 (9.69)
Depression
(PHQ)
T0 5.66 (4.07) 4.87 (4.96)
T13 4.61 (3.72) 3.82 (2.65)
T30 3.93 (4.16) 4.84 (5.73)
T42 4.14 (3.66) 3.68 (3.45)
Problem solving
(SPSI-R)
T0 133.36 (19.86) 137.34 (18.36)
T13 138.86 (12.43) 135.56 (20.92)
T30 137.48 (14.11) 139.25 (17.29)
T42 140.41 (17.46) 136.63 (18.58)
Self-efficacy
(DGSS)
T0 31.79 (3.92) 32.20 (5.28)
T13 33.28 (4.42) 32.38 (4.95)
T30 33.17 (4.15) 31.94 (5.10)
T42 33.07 (4.95) 31.57 (6.04)
HADS Hospital Anxiety and Depression Scale, EORTC QLQ-C30 Euro-
pean Organization for Research and Treatment of Cancer Quality of Life
Questionnaire-C30, SPSI-R Social Problem Solving Inventory-Revised,
DGSS Dutch General Self-efficacy Scale, PHQ Patient Health Question-
naire, STAI Spielberger State-Trait Anxiety Inventory
Table 4 Test statistics and effect sizes of the differences in primary and
secondary outcomes between the experimental group and the control
group, from linear mixed model analyses




Condition*T13 1.40 0.16 0.28
Condition*T30 0.47 0.64 0.10
Condition*T42 0.50 0.62 0.11
Depression
(HADS subscale)
Condition*T13 1.31 0.19 0.30
Condition*T30 −0.10 0.92 −0.02
Condition*T42 0.05 0.96 0.01
Anxiety
(HADS subscale)
Condition*T13 0.90 0.37 0.18
Condition*T30 0.97 0.33 0.21
Condition*T42 0.87 0.39 0.19
Physical functioning
(EORTC QLQ-C30)
Condition*T13 −1.00 0.32 −0.19
Condition*T30 −0.53 0.60 −0.11




Condition*T13 −2.32 0.02* −0.43
Condition*T30 −0.94 0.35 −0.19
Condition*T42 0.12 0.91 0.02
Role functioning
(EORTC QLQ-C30)
Condition*T13 −0.09 0.93 −0.02
Condition*T30 −0.52 0.60 −0.11
Condition*T42 0.15 0.89 0.03
Anxiety
(STAI)
Condition*T13 0.99 0.33 0.21
Condition*T30 −0.29 0.77 −0.07
Condition*T42 0.16 0.87 0.04
Depression
(PHQ)
Condition*T13 0.09 0.93 0.02
Condition*T30 −1.32 0.19 −0.31
Condition*T42 −0.54 0.59 −0.13
Problem-solving
(SPSI-R)
Condition*T13 1.59 0.11 0.29
Condition*T30 1.02 0.31 0.20
Condition*T42 1.61 0.11 0.32
Self-efficacy
(DGSS)
Condition*T13 0.99 0.33 0.19
Condition*T30 1.27 0.21 0.26
Condition*T42 1.40 0.16 0.29
HADS Hospital Anxiety and Depression Scale, EORTC QLQ-C30 Euro-
pean Organization for Research and Treatment of Cancer Quality of Life
Questionnaire-C30, SPSI-R Social Problem Solving Inventory-Revised,
DGSS Dutch General Self-efficacy Scale, PHQ Patient Health Question-
naire, STAI Spielberger State-Trait Anxiety Inventory
*P<0.05
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favor of the care as usual group (t=−2.32, P=0.02, d=−0.43))
(Table 4).
The per-protocol analyses yielded similar results as the
intention-to-treat analyses, except for the difference on
EORTC emotional functioning at 13 weeks: This finding
was non-significant in the per-protocol analysis which includ-
ed only patients who had completed at least four lessons of the
Internet-based self-help program.
Discussion
The purpose of the present study was to evaluate a stepped
care program aimed at treating psychological distress and im-
proving QOL in patients with hematological malignancies
treated with auto-SCT. The program as presented here was
not effective in treating psychological distress in this patient
group. The uptake of the program appeared to be very limited.
Few randomized controlled trials have previously evaluat-
ed treatment for psychological distress in hematological can-
cer patients. An Internet-based program for coping with can-
cer found an effect on fighting spirit, but not on psychological
distress [31]. Another intervention was successful in decreas-
ing anxiety during hospitalization [32]. More broadly, in can-
cer patients, many trials have focused on treating psycholog-
ical distress. These trials differ substantially with regard to
study designs and studied treatments, but in general, small-
to-medium effect sizes have been reached [33]. Reflecting on
our trial, the response rate of 61.1 % was relatively high.
However, the uptake of our intervention was low, which lim-
ited the possibility of finding an intervention effect: Of the 47
patients in the experimental condition, only 24 started with the
Internet-based self-help intervention. More intensive treat-
ment options (step 3 of the program) were not chosen.
Several factors may explain the low uptake of the interven-
tion program. The first explanation concerns the prevalence of
psychological distress. Prevalence rates of elevated anxiety
and depressive symptoms at baseline were 6.5 and 7.5 %,
respectively; these are equal to some, but lower than other
rates found in observational studies [4, 7–10]. Mean distress
scores in our sample were lower than in a Dutch population
sample of persons aged 18–65 years [23]. The low scores and
prevalence rates probably indicate a low need for psycholog-
ical care in our patient group and/or a high standard of usual
care, as 10.3 % of our study participants received psycholog-
ical or psychiatric care outside of the study program. Together,
the low uptake of the intervention, low distress scores, and
high standard of usual care probably led to a reduced contrast
between the experimental group and the control group.
Given patients’ life-threatening illness and stressful treat-
ment, we assumed beforehand that improved problem-solving
skills could help to decrease psychological distress and im-
prove QOL in all patients. We therefore offered the stepped
care program to all patients in the experimental study arm,
regardless of their level of psychological distress. This may
have limited our potential to show an intervention effect: In
recent years, it has become clear that patients with elevated
levels of distress are the patients most likely to benefit from
psychological interventions [33, 34]. Trials showing effective
treatment results either only included patients with psycholog-
ical distress (e.g., [35, 36]) or recruited patients via advertise-
ments [31] and thereby pre-selected study participants with a
higher need for and interest in an intervention aimed at psy-
chological distress. However, in our trial, subanalyses with
only distressed patients did not show a significant intervention
effect. It is suggested that future interventions should target
specific care needs, instead of being offered to all patients. In
this respect, it is important to note that presence of psycholog-
ical distress and need for support not necessarily coincide
[37]. Besides, whether psychological distress is the best indi-
cator for guiding supportive care is questionable. Targeting
care needs could be considered instead [38], in which case a
focus on physical and cognitive-emotional needs could be
desirable [39]. In addition, cost-effectiveness is an important
aspect when implementing interventions and should be eval-
uated in future studies.
A second factor influencing the uptake of our intervention
program could be the nature of the intervention itself. The
Internet-based self-help intervention, which was the second
step of the program, has previously been shown to be effective
[18]. Our dropout rates were relatively high, however. When
evaluating the reasons for dropout, the intensity of the pro-
gram appeared to be too high for those patients who felt ca-
pable of coping with their problems themselves. For other
patients, the timing of offering the intervention did not match
their needs. The third and most intensive step of the program,
consisting of face-to-face treatment or other care options, was
not chosen by any patient. One interpretation of our results is
that Problem Solving Treatment as specific psychotherapeutic
technique, as well as the opportunity to receive face-to-face
treatment, may not match the needs of the majority of patients.
Most hematological cancer patients seem resilient when it
comes to coping with their disease and QOL impairments. If
needed, other forms of psychological support could be more
suitable, such as supporting self-management, or guided peer
support, reserving psychotherapeutic care options for those
patients with an anxiety or depressive disorder.
Other factors that may have influenced the uptake of the
intervention are current health care provision, the timing of
offering treatment, and logistic issues. First, during the study
period, 10.3 % of the study participants received psychologi-
cal or psychiatric care outside of the study. This could reflect
the relatively high accessibility of additional supportive care
in the Dutch health care system. Second, in our stepped care
program, providing patients with psychological care options
at 6 weeks after transplantation may not have been
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appropriate. Emotional problems might occur at that point in
time, but also in an earlier stage of the disease or treatment
process or, conversely, in a later stage. It has been proposed
that emotional concerns may only come up after acute phys-
ical problems have been dealt with [40]. The timing of offer-
ing treatment should be flexible, fitting individual patients’
needs. Finally, the treatment location in step 3 of the stepped
care program may have led to logistic barriers. This step was
organized in the hospitals where patients had received their
auto-SCT. However, about 40 % of the patients were
redirected to their local hospital for follow-up care after au-
to-SCT.
Concluding, the stepped care program as presented in the
current study was not effective in decreasing psychological
distress. This could mainly be explained by the low uptake
of the intervention, probably because of the low baseline
levels of psychological distress. Also, whether psychological
distress is the best indicator for guiding supportive care is
questionable. Future research could look into treatments that
target patients’ care needs, and into other ways of support than
psychotherapeutic treatment.
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